Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead

AIDS. 2009 May 15;23(8):1027. doi: 10.1097/QAD.0b013e328329d04b.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenine / analogs & derivatives
  • Anti-HIV Agents / adverse effects*
  • Developing Countries
  • Drug Therapy, Combination / methods
  • HIV Infections / drug therapy*
  • Humans
  • Organophosphonates
  • Stavudine / adverse effects*
  • Tenofovir
  • Treatment Failure

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Tenofovir
  • Stavudine
  • Adenine